Share Facebook Twitter LinkedIn Pinterest Email Ibotta rallies on Q3 results; Goldman removes Sell rating
Strata critical medical signals 2027 high-teens organic adjusted EBITDA growth while authorizing $20M buyback (NASDAQ:SRTA)November 3, 2026